BMJ Group Retina Logo
BMJ Group Retina Logo
Find an expert2024-06-07T09:48:34+00:00

Find an expert

Our panel of editors are available for interview

Filters
Expertise

Dr Brandy Shillace

2024-06-27T15:55:02+00:00Expertise : , , , , |

Editor-in-Chief of Medical Humanities

Contact

Brandy Schillace, PhD, is Senior Research Associate and Public Engagement and Programs Leader for the Dittrick Museum of Medical History. Dr Schillace writes about intersections of medicine, history, and literature. For ten years, she managed the medical anthropology journal, Culture, Medicine and Psychiatry, and edited its first medical humanities special issue. Brandy’s recent books include Death’s Summer Coat (2016), Clockwork Futures (2017) and Mr Humble and Dr Butcher: A Monkey’s Head, the Pope’s Neuroscientist, and the Quest to Transplant the Soul (2021).

Professor Gisli Jenkins

2024-06-27T16:02:50+00:00Expertise : , |

Chair of the Editorial Board for BMJ Open Respiratory Research

Contact

Professor Gisli Jenkins is an NIHR Research Professor and holds the Margaret Turner-Warwick Chair of Thoracic Medicine at Imperial College London, Head of the Margaret Turner-Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute. Prof Jenkins’ research focuses on Interstitial Lung Diseases, and Pulmonary Fibrosis in particular. He is the Principal Investigator of a number of longitudinal observational studies including the PROFILE study, the INJUSTIS Study, the UKILD Post COVID ILD study as well as the DEMISTIFI Multi-Morbidity consortium.

 

Professor Ronald F. van Vollenhoven

2024-06-27T16:03:26+00:00Expertise : , , |

Editor-in-Chief of Lupus Science & Medicine

Contact

Professor Ronald F. van Vollenhoven is a distinguished rheumatologist and immunologist, known for his significant contributions in the field. He currently holds the position of Chair of the Department of Rheumatology and Clinical Immunology at Amsterdam UMC and directs the Amsterdam Rheumatology Centre. With a background in immunology and extensive training in Internal Medicine and Rheumatology, he has dedicated his career to the development and evaluation of biological and immunomodulatory treatments for rheumatic diseases. Dr. Van Vollenhoven has played a pivotal role in establishing crucial registries, including the Stockholm registry for biological therapies (STURE database), and has been a principal investigator in numerous clinical trials.

Dr Declan Walsh

2024-06-27T15:55:41+00:00Expertise : , , , , , , , |

Editor-in-Chief of BMJ Supportive & Palliative Care

Contact

A pioneer in palliative medicine, Dr Declan Walsh is an internationally renowned physician, researcher, educator and administrator. He developed the first palliative care programme in the United States. In recognition of his achievements, he received the John Mendelsohn Award from MD Anderson Cancer Centre, a lifetime achievement award from the Multinational Association for Supportive Care in Cancer and a Visionary Award from the American Academy of Hospice and Palliative Medicine.

Dr Ellen Weber

2024-06-27T15:56:11+00:00Expertise : , , , , , |

Editor-in-Chief of Emergency Medicine Journal

Contact

Dr Ellen Weber is an emergency medicine physician in San Francisco, California. She received her medical degree from Harvard Medical School and has been in practice for more than 20 years. She has worked clinically in community, county and academic emergency departments, and conducts research in topics related to health policy. She is currently a Professor of Emergency Medicine and Vice Chair at UCSF.

Professor Ganesan Karthikeyan

2024-06-27T16:24:49+00:00Expertise : , , , , , |

Editor-in-Chief Open Heart

Contact

Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.

Go to Top